Menu
Back to User profile » Prof. Dr. Yu Kyong Kim
Papers published by Prof. Dr. Yu Kyong Kim:
Pharmacokinetics and Pharmacodynamics of Esomezol DR, a New Dual Delayed-Release Formulation of Esomeprazole 20 Mg or 40 Mg, in Healthy Subjects
Kim HC, Yang E, Ban MS, Kim YK, Hong SH, Jung J, Jang IJ, Lee S
Drug Design, Development and Therapy 2023, 17:1115-1124
Published Date: 12 April 2023
No Relevant Pharmacokinetic Drug–Drug Interaction Between the Sodium-Glucose Co-Transporter-2 Inhibitor Empagliflozin and Lobeglitazone, a Peroxisome Proliferator-Activated Receptor-γ Agonist, in Healthy Subjects
Kim YK, Hwang JG, Park MK
Drug Design, Development and Therapy 2021, 15:1725-1734
Published Date: 28 April 2021
Effect of food on the pharmacokinetic characteristics of a single oral dose of LCB01-0371, a novel oxazolidinone antibiotic
Sunwoo J, Kim YK, Choi Y, Yu KS, Nam H, Cho YL, Yoon S, Chung JY
Drug Design, Development and Therapy 2018, 12:1707-1714
Published Date: 11 June 2018
Pharmacokinetics and tolerability of eletriptan hydrobromide in healthy Korean subjects
Kim YK, Shin KH, Alderman J, Yu KS, Jang IJ, Lee S
Drug Design, Development and Therapy 2018, 12:331-337
Published Date: 19 February 2018
A comparative pharmacokinetic and tolerability analysis of the novel orotic acid salt form of tenofovir disoproxil and the fumaric acid salt form in healthy subjects
Kim YK, Choi MJ, Oh TY, Yu KS, Lee S
Drug Design, Development and Therapy 2017, 11:3171-3177
Published Date: 6 November 2017
New tablet formulation of tacrolimus with smaller interindividual variability may become a better treatment option than the conventional capsule formulation in organ transplant patients
Kim YK, Kim A, Park SJ, Lee H
Drug Design, Development and Therapy 2017, 11:2861-2869
Published Date: 28 September 2017